Rossella Cannarella, lead investigator on the study, this dual action means tirzepatide could become a first-line treatment option for men whose testosterone issues are rooted in metabolic health, rather than structural damage to the testes
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two primary indications: type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
These are usually mild and resolve spontaneously
NOTICIAS RELACIONADAS La CE autoriza a Lilly la comercializacin de su pluma KwikPen precargada con tirzepatida La SEEN visita el Congreso de los Diputados con la Asociacin Diabetes Madrid Espaa increment un 135 % sus problemas con el suministro de frmacos en 2023 Novo Nordisk present ayer en rueda de prensa la llegada al mercado espaol de Rybelsus (semaglutida oral), una innovacin teraputica que ana, en un comprimido, la eficacia y seguridad de un arGLP-1
By stimulating endogenous growthhormone release, supporting melatonin production, and tempering nighttime cortisol spikes, these peptides deepen slowwave sleep, enhance recovery, and stabilize overall endocrine balance
Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta-blockers) [see Drug Interactions (7)], or in patients who experience recurrent hypoglycemia
